Research Article
Field Deployment of a Mobile Biosafety Laboratory Reveals the Co-Circulation of Dengue Viruses Serotype 1 and Serotype 2 in Louga City, Senegal, 2017
Table 1
Epidemiologic and clinical characteristics of suspected and confirmed dengue fever cases, Louga, Senegal, 2017.
| | | Negatives (n = 829) | Positives (n = 131) | Total (n = 960) | value |
| | Age | | | | 0.1492 | | Median | 22 | 20 | 21 | | | Q1, Q3 | 12, 33 | 15, 29.75 | 13, 32 | | | Age group | | | | <0.0011 | | N-Miss | 36 | 05 | 41 | | | [0, 10] | 174 (21.9%) | 7 (5.6%) | 181 (19.7%) | | | [10, 20] | 207 (26.1%) | 60 (47.6%) | 267 (29.1%) | | | [20, 30] | 178 (22.4%) | 35 (27.8%) | 213 (23.2%) | | | [30, 40] | 120 (15.1%) | 20 (15.9%) | 140 (15.2%) | | | [40, 50] | 58 (7.3%) | 4 (3.2%) | 62 (6.7%) | | | [50, 90] | 56 (7.1) | 0 (0.0%) | 56 (6.1%) | | | Sex | | | | 0.0901 | | F | 452 (54.5%) | 61 (46.6%) | 513 (53.4%) | | | M | 377 (45.5%) | 70 (53.4%) | 447 (46.6%) | | | Arthralgia | | | | <0.0011 | | No | 341 (41.1%) | 27 (20.6%) | 368 (38.3%) | | | Yes | 488 (58.9%) | 104 (79.4%) | 592 (61.7%) | | | Asthenia | | | | 0.0221 | | No | 475 (57.3%) | 61 (46.6%) | 536 (55.8%) | | | Yes | 354 (42.7%) | 70 (53.4%) | 424 (44.2%) | | | Headache | | | | 0.1101 | | No | 88 (10.6%) | 8 (6.1%) | 96 (10.0%) | | | Yes | 741 (89.4%) | 123 (93.9%) | 864 (90.0%) | | | Retro-orbital pain | | | | 0.1591 | | No | 825 (99.5%) | 129 (98.5%) | 954 (99.4%) | | | Yes | 4 (0.5%) | 2 (1.5%) | 6 (0.6%) | | | Rash | | | | 0.9611 | | No | 823 (99.3%) | 130 (99.2%) | 953 (99.3%) | | | Yes | 6 (0.7%) | 1 (0.8%) | 7 (0.7%) | | | Myalgia | | | | 0.0131 | | No | 470 (56.7%) | 59 (45%) | 529 (55.1%) | | | Yes | 359 (43.3%) | 72 (55%) | 431 (44.9%) | | | Outcome | | | | 0.6581 | | Died | 10 (1.2%) | 1 (0.8%) | 11 (1.1%) | | | Living | 819 (98.8%) | 130 (99.2%) | 949 (98.9%) | | | Symptoms-sampling delay | | | | 0.0832 | | Median | 2.000 | 1.000 | 2.000 | | | Q1, Q3 | 1.000, 3.000 | 1.000, 2.000 | 1.000, 2.000 | | | Medical structure | | | | <0.0011 | | | 15 (1.8%) | 0 (0.0%) | 15 (1.6%) | | | DS Dahra | 117 (14.1) | 8 (6.1%) | 125 (13%) | | | DS Darou Mousty | 185 (22.3%) | 12 (9.2%) | 197 (20.5) | | | DS Kebemer | 19 (2.3%) | 0 (0%) | 19 (2.0%) | | | DS KMS | 41 (4.9%) | 4 (3.1%) | 45 (4.7%) | | | DS Koki | 15 (1.8%) | 2 (1.5%) | 17 (1.8%) | | | DS Linguere | 28 (3.4%) | 0 (0.0%) | 28 (2.9%) | | | DS Louga | 380 (45.8%) | 105 (80.2%) | 485 (50.3%) | | | DS Sakal | 29 (3.5%) | 0 (0.0%) | 29 (3.0%) | |
|
|
Significant values are indicated in bold. “1” stands for χ2-test or Fisher’s exact test. “2” stands for the Kruskal–Wallis test. |
